The company expired its plan on September 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.68 USD | +8.93% | +10.98% | +3.78% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.78% | 8.01M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Pasithea Therapeutics Corp.'s Equity Buyback announced on July 20, 2023 has expired with 5,323,451 shares, representing 20.36% for $3.73 million.